OMER: Omeros Corporation
Performance
OMER +166.31%
Watchlist
Select an item
Summary
OMER at a glance
OMER returned +166.31% over the past year and +18.32% a year over five years. Its worst drop in that year was -49.52%, smaller than 23% of stocks on Redstone, and its Sharpe ratio of 1.32 beats 87% of stocks on Redstone. It pays no dividends.
Current Drawdown
-16.63%
Rolling Volatility
69.85%
Actions
Metrics
Risk Indicators
Alpha130.35%
Beta1.62x
Sharpe1.32
Sortino2.92
Omega1.37
Calmar3.36
Martin5.49
Profile
About OMER
Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.3B
- Listed
- Oct 2009
- Employees
- 175
- Headquarters
- Seattle, WA
- Website
- omeros.com
Comparisons